In this perspective, we hypothesize that PTH-rP and PTH-R1 are upregulated in placentas from women with increased insulin resistance and metabolic syndrome, and their overexpression should be considered a compensative mechanism aiming to provide an increased calcium-mediated insulin sensitivity in women with GDM and increased insulin resistance. Here, INS is linked to gestational diabetes.